R&S Holdings Acquires Innovo Detox: Expanding Addiction Treatment Services
Introduction
R&S Holdings, a prominent behavioral health organization, has announced the acquisition of Innovo Detox, a residential addiction treatment operator. This move marks R&S Holdings' entry into Pennsylvania and expands its network of behavioral health services.
About R&S Holdings and Innovo Detox
R&S Holdings is a behavioral health company with a diverse portfolio of addiction treatment and behavioral health services through its subsidiaries. They currently operate over 35 facilities in Maryland.
Innovo Detox, based in Abbottstown, Pennsylvania, offers detox and residential treatment for substance use disorders, bringing medically supervised detox services to R&S Holdings' network for the first time. The facility has 52 beds and is managed by Polaris Detox LLC, which was acquired as part of the overall deal.
Financial and Strategic Implications
While the financial terms of the acquisition remain confidential, the transaction successfully closed two weeks ago. This addition opens new geographic markets for R&S Holdings and strengthens its presence in Pennsylvania through Innovo Detox and potential future M&A activities.
The company plans to integrate Innovo Detox seamlessly into its network, with integration processes already underway. Looking ahead, R&S Holdings aims to expand services throughout Pennsylvania and potentially beyond the Mid-Atlantic region.
Insurance and Patient Mix
Innovo Detox primarily serves commercial payers but also caters to Medicaid beneficiaries. R&S Holdings focuses on deals with companies providing quality substance use disorder care through residential or outpatient services, including Medicaid and commercial insurance coverage.
This Markdown version maintains the key information while adhering to the specified formatting guidelines.